Detalhe da pesquisa
1.
Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial.
BMC Neurol
; 21(1): 126, 2021 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33740902
2.
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide.
J Pharmacol Exp Ther
; 369(1): 26-36, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30643015
3.
Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.
J Headache Pain
; 18(1): 17, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28176235
4.
A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
J Headache Pain
; 18(1): 31, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28251391
5.
Acupuncture in the treatment of headache: a traditional explanation of an ancient art.
Headache
; 55(3): 457-64, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25683658
6.
Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.
Headache
; 55(4): 529-42, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25828648
7.
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
Headache
; 55(1): 88-100, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25355310
8.
AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Headache
; 55(5): 621-35, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25941016
9.
Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.
Headache
; 54(4): 640-54, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24102322
10.
Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function.
Headache
; 53(4): 656-64, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23406052
11.
Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
Headache
; 52(5): 749-64, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22188311
12.
The development of a survey to measure completeness of response to migraine therapy.
Headache
; 52(4): 550-72, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22486740
13.
Naming migraine and those who have it.
Headache
; 52(2): 283-91, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21929663
14.
Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Headache
; 52(1): 57-67, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22078129
15.
The bowel and migraine: update on celiac disease and irritable bowel syndrome.
Curr Pain Headache Rep
; 16(3): 278-86, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22447132
16.
A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
Headache
; 51(7): 1078-86, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21631494
17.
Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Headache
; 51(8): 1202-11, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21812775
18.
Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.
Headache
; 51(3): 356-368, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21039453
19.
A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
Headache
; 51(1): 21-32, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21070228
20.
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
Headache
; 51(5): 664-73, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21521204